(Q36238733)

13 August 2017

1 reference

title

DNA vaccines against tropical parasitic diseases (English)

1 reference

13 August 2017

Akram A Da'dara

1

1 reference

PubMed ID

16117713

13 August 2017

Donald A Harn

series ordinal

2

1 reference

13 August 2017

1 August 2005

1 reference

Expert Review of Vaccines

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

4

1 reference

13 August 2017

575-589

1 reference

DNA vaccines: immunology, application, and optimization*

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA immunization via intramuscular and intradermal routes using a gene gun provides different magnitudes and durations on immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Gene-based vaccines and immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

New insights into the epidemiology of malaria relevant for disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Progress and challenges for malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Transmission blocking malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Leishmaniasis: current status of vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Optimization of DNA vaccination against cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

The immunology of susceptibility and resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Genetic vaccination against leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

History of sleeping sickness (African trypanosomiasis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Resurrecting the resurrection drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Molecular players of homologous recombination in protozoan parasites: implications for generating antigenic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Immunization with a tubulin-rich preparation from Trypanosoma brucei confers broad protection against African trypanosomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Detection of praziquantel resistance in schistosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Blueprint for schistosomiasis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

New hope for vaccine against schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Schistosomiasis vaccine development: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Field testing of Schistosoma japonicum DNA vaccines in cattle in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Recombinant vaccinia viruses and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain used in a murine immunization-challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Vaccine strategies against schistosomiasis: from concepts to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Antibody responses to Brugia malayi antigens induced by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

The Secreted Larval Acidic Proteins (SLAPs) of Onchocerca spp. are encoded by orthologues of the alt gene family of Brugia malayi and have host protective potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

A global call for new polio vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.4.575

21 January 2018

Identifiers

DOI

10.1586/14760584.4.4.575

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/shqnh7fdkvb43miue3ahitwmpe

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_shqnh7fdkvb43miue3ahitwmpe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/shqnh7fdkvb43miue3ahitwmpe

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/shqnh7fdkvb43miue3ahitwmpe